Omega Therapeutics company info

What does Omega Therapeutics do?
Omega Therapeutics (NASDAQ:OMGA) specializes in harnessing the power of genomic programming to develop a new class of DNA-sequence-targeting, mRNA-expressing therapies with the objective of revolutionizing the treatment across multiple disease areas. Their projects primarily focus on leveraging their proprietary Omega Epigenomic Programming™ platform to precisely tune gene expression, without altering the native DNA sequence, facilitating the development of therapies aimed at a broad range of diseases including oncology, regenerative medicine, and autoimmune diseases. Omega aims to pioneer a new era of genomic medicine, with the goal of unlocking the full potential of the human genome to conquer diseases at their genetic roots.
Omega Therapeutics company media
Company Snapshot

Is Omega Therapeutics a public or private company?

key
Ownership
Public

How many people does Omega Therapeutics employ?

people
Employees
94

What sector is Omega Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Omega Therapeutics?

location pin
Head Office
Cambridge, United States

What year was Omega Therapeutics founded?

founded flag
Year Founded
2016
What does Omega Therapeutics specialise in?
/Genomic Medicine /Epigenomic Programming /Epigenomic Controllers /Therapeutic Diseases Treatment /Genome Regulation /Disease Intervention

What are the products and/or services of Omega Therapeutics?

Overview of Omega Therapeutics offerings
OTX-2002, a programmable epigenetic mRNA therapy targeting the MYC oncogene for hepatocellular carcinoma.
OTX-2101, addressing solid tumors through epigenetic modulation.
Development of a platform for modularly programming or reprogramming gene expression without altering the DNA sequence.
Partnerships aimed at expanding the application of epigenetic therapy across various diseases.

Who is in the executive team of Omega Therapeutics?

Omega Therapeutics leadership team
  • Mr. Mahesh  Karande
    Mr. Mahesh Karande
    President, CEO & Board Director
  • Ms. Ling  Zeng Esq., J.D.
    Ms. Ling Zeng Esq., J.D.
    Chief Legal & Administrative Officer and Secretary
  • Dr. Yan  Moore M.D.
    Dr. Yan Moore M.D.
    Chief Medical Officer
  • Mr. Joshua  Reed M.B.A.
    Mr. Joshua Reed M.B.A.
    Chief Financial Officer
  • Dr. Sivakesava  Sakhamuri Ph.D.
    Dr. Sivakesava Sakhamuri Ph.D.
    Senior VP and Head of Technical Operations & Quality
  • Dr. Thomas  McCauley Ph.D.
    Dr. Thomas McCauley Ph.D.
    Chief Scientific Officer
  • Mr. Anthony  Mullin
    Mr. Anthony Mullin
    Chief People Officer
  • Mr. Charles  O'Donnell Ph.D.
    Mr. Charles O'Donnell Ph.D.
    VP and Head of Computational Genomics & Data Sciences